-
Non Regulatory June 16, 2026Vivesto reports positive results from i.v. Cantrixil PK/toxicology study
-
Regulatory June 5, 2026Vivesto appoints Björn Svanström as CFO
-
Regulatory May 29, 2026New number of shares and votes in Vivesto
Vivesto published its interim report for Q1 2026 on May 7, 2026, at 08.00 am CEST.